Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 8.1 Mln
15/05/2025 07:24
May 15 (Reuters) - Elicera Therapeutics AB ELIC.ST: Q1 ADJUSTED EPS SEK -0.22 Q1 OPERATING LOSS AMOUNTS TO SEK 8.1 MILLION Source text: ID:nWkr2nYkt0 Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent